The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis

Authors:

Abstract
To estimate the impact of persistence on cost-effectiveness of subcutaneous tumor necrosis factor-α inhibitors (SC-TNFis) from healthcare and societal perspectives in a United Kingdom ankylosing spondylitis (AS) population using a recently published Markov cohort model.
Funding Information
  • Merck

This publication has 30 references indexed in Scilit: